Abiraterone Acetate Tablet
Product Images NDC 60505-4327

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Abiraterone Acetate (NDC 60505-4327). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Apotex Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure 2 (Figure 2)

Figure 2 (Figure 2)
The provided text seems to be a table showing the number of subjects without death in a study done using Abiraterone acetate and a placebo. The subjects were observed over a period of 60 months from randomization. It appears that Abiraterone acetate lowered the number of subjects without death compared to the placebo.*
FDA Label Image

Figure 3 (Figure 3)

Figure 3 (Figure 3)
FDA Label Image

Figure 4

Figure 4
FDA Label Image

Figure 1 (Graph 1)

Figure 1 (Graph 1)
This appears to be a graph showing the survival rate of patients over time (measured in months) for a medical study involving a treatment called "Abiteron" compared to a control group who were given a placebo. The percentages on the vertical axis indicate the survival rate, and the horizontal axis shows the time to death in months. However, the graph is not very clear due to the way it was converted via , and some of the characters are not readable.*
FDA Label Image

Structure (Structure)

Structure (Structure)
FDA Label Image

Container-label-250mg (Container Label 250mg)

Container-label-250mg (Container Label 250mg)
Each tablet of Abiraterone Acetate USP contains 250mg of Abiraterone Acetate. The tablets should be stored between 20°C to 25°C (68°F to 77°F) and must be kept away from children. It should be dispensed in a tightly closed container as defined in the USP. The medication is for adults and the usual dosage should be followed as instructed in the package insert. Swallow the tablet whole, do not crush or chew. Pregnant or nursing women should avoid handling the medication and gloves must be worn. The pharmacist should dispense with the patient information leaflet available at a specified website. This product is manufactured by Apotex Ing in Toronto, Canada and is manufactured for Apotex Corp in Weston, Florida.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.